FY2025 EPS Estimates for Centene Raised by Cantor Fitzgerald

Centene Corporation (NYSE:CNC) – Equities researchers at Cantor Fitzgerald lifted their FY2025 EPS estimates for Centene in a note issued to investors on Thursday, October 30th. Cantor Fitzgerald analyst S. James now expects that the company will post earnings per share of $2.02 for the year, up from their previous forecast of $1.71. Cantor Fitzgerald has a “Neutral” rating and a $41.00 price objective on the stock. The consensus estimate for Centene’s current full-year earnings is $6.86 per share. Cantor Fitzgerald also issued estimates for Centene’s FY2026 earnings at $2.83 EPS.

CNC has been the topic of several other reports. Morgan Stanley increased their price objective on shares of Centene from $28.00 to $38.00 and gave the company an “equal weight” rating in a report on Tuesday, October 14th. Cowen reaffirmed a “hold” rating on shares of Centene in a report on Friday. Deutsche Bank Aktiengesellschaft raised their price target on shares of Centene from $24.00 to $32.00 in a research note on Friday, October 31st. Barclays set a $44.00 price target on shares of Centene and gave the stock an “equal weight” rating in a research report on Tuesday. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of Centene in a research report on Wednesday, October 29th. Three investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $41.53.

Centene Stock Performance

CNC opened at $36.00 on Monday. The company has a quick ratio of 1.10, a current ratio of 1.08 and a debt-to-equity ratio of 0.83. The company has a market cap of $17.69 billion, a price-to-earnings ratio of -3.33, a PEG ratio of 1.24 and a beta of 0.48. Centene has a 52-week low of $25.08 and a 52-week high of $66.81. The firm’s fifty day simple moving average is $33.83 and its two-hundred day simple moving average is $41.08.

Centene (NYSE:CNC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.71. The business had revenue of $49.69 billion for the quarter, compared to the consensus estimate of $47.50 billion. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The company’s revenue was up 18.2% compared to the same quarter last year. During the same period last year, the firm posted $1.62 earnings per share.

Hedge Funds Weigh In On Centene

Institutional investors have recently bought and sold shares of the company. Quarry LP purchased a new position in Centene during the first quarter worth about $26,000. Mowery & Schoenfeld Wealth Management LLC purchased a new position in Centene during the third quarter worth about $27,000. WPG Advisers LLC raised its stake in shares of Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after acquiring an additional 282 shares during the period. Bogart Wealth LLC lifted its holdings in shares of Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after acquiring an additional 991 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC boosted its position in shares of Centene by 54.9% during the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after purchasing an additional 390 shares during the period. 93.63% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Sarah London bought 19,230 shares of Centene stock in a transaction on Friday, August 8th. The shares were bought at an average cost of $25.50 per share, with a total value of $490,365.00. Following the completion of the purchase, the chief executive officer directly owned 845,275 shares of the company’s stock, valued at approximately $21,554,512.50. This trade represents a 2.33% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.36% of the stock is owned by company insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.